AVALON GLOBOCARE CORP. (YOOV)
Investment Snapshot
- P/B of 1.77 — trading above book value
- Piotroski F-Score 1/9 — signs of financial weakness
- Loss-making — negative ROE of -193.7%
- Revenue growing at 6% annually
AVALON GLOBOCARE CORP. (YOOV) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $16 million . Key value metrics: P/B ratio 1.77, Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
AVALON GLOBOCARE CORP. — Fundamental Analysis Summary
On financial health, YOOV shows a weak Piotroski F-Score of 1/9, a signal of deteriorating financial health, and negative return on equity of -193.7%, and minimal leverage with a debt-to-equity ratio of 0.12.
StockPik's composite Value Score for YOOV is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
YOOV shows revenue growing at 6% year-over-year, with earnings declining at 131%.